Travere Therapeutics, Inc. · NASDAQ:TVTX
Perceptive Advisors LLC's stake in Travere Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Perceptive Advisors LLC's stake in Travere Therapeutics, Inc. fell to 4.80%, 4,278,180 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 4,278,180
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 4.80% | 4,278,180 |
| Joseph Edelman | 4.80% | 4,278,180 |
| Perceptive Life Sciences Master Fund, Ltd. | 4.80% | 4,278,180 |
Source
Related
- Travere Therapeutics, Inc.
- Perceptive Advisors LLC
- Travere Therapeutics, Inc. shareholders
- Schedule 13G · Perceptive Advisors LLC · Oct 14, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026